[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Metastatic Cancer Treatment Market Size study, by Treatment Type (Chemotherapy, Immunotherapy, Hormone Therapy, and Other Therapies), Type of Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Colorectal Cancer, and Other Type of Cancer), End Users (Hospitals, Clinics, and Other End Users), and Regional Forecasts 2022-2028

August 2022 | 200 pages | ID: G8CCB8007A1BEN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Metastatic Cancer Treatment Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.1% over the forecast period 2022-2028. A kind of cancer known as metastatic cancer goes from its original site to another portion of the body. For several cancer types, it is also referred to as stage IV cancer. The process through which cancer cells spread to other parts of the body is known as metastasis. Treatment for metastatic cancer aims to stop the spread or growth of the illness. The market growth is driven by growing Demand of Stem Cell Therapy to Treat Metastatic Cancer and increasing Prevalence of Metastatic Cancer Worldwide. For instance, more than 168,000 women in the United States are expected to have metastatic breast cancer in 2020, according to predictions from the Susan G. Komen Metastatic Breast Cancer Organization. Similarly, according to data from the American Cancer Society's Cancer Facts & Figures 2020, metastasis is responsible for more than 90% of cancer-related deaths. Metastatic cancer may still manifest even if a patient completes a successful course of treatment, undergoes yearly exams, or waits five, 10, or more years following diagnosis. Furthermore, growing strategic developments such as therapy launches, acquisitions, and mergers and surge in research and development of chemotherapy medicines create lucrative opportunities in the upcoming years. However, high Cost of Oncology Treatment impedes the growth of the market over the forecast period of 2022-2028

The key regions considered for the global Metastatic Cancer Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the global market share owing to identification of new drugs to treat metastatic cancer and high prevalence of metastatic cancer. However, Asia Pacific expected to be the fastest growing region due to supportive government initiatives and increasing number of healthcare infrastructural establishments in the region.

Major market players included in this report are:
Bristol Myers Squibb Company
Eli Lilly and Company
AstraZeneca
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd.
Novartis AG
Merck and Co, Inc.
Amgen Inc.
Abbvie Inc.
Johnson and Johnson Services Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Cancer:
Breast Cancer
Lung Cancer
Prostate Cancer
Melanoma
Colorectal Cancer
Others (Liver Cancer, Esophageal Cancer, among others)
By Treatment Type:
Chemotherapy
Immunotherapy
Hormone Therapy
Others (Radiation Therapy, Surgery, among others)
By End User:
Hospitals
Clinics
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Metastatic Cancer Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  1.2.1. Metastatic cancer treatment Market, by region, 2020-2028 (USD Million)
  1.2.2. Metastatic cancer treatment Market, by Types of Cancer, 2020-2028 (USD Million)
  1.2.3. Metastatic cancer treatment Market, by Treatment Type, 2020-2028 (USD Million)
  1.2.4. Metastatic cancer treatment Market, by End User, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL METASTATIC CANCER TREATMENT MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL METASTATIC CANCER TREATMENT MARKET DYNAMICS

3.1. Metastatic cancer treatment Market Impact Analysis (2020-2028)
  3.1.1. Market Drivers
    3.1.1.1. Growing demand of stem cell therapy to treat metastatic cancer
    3.1.1.2. Increasing prevalence of metastatic cancer worldwide
  3.1.2. market challenges
    3.1.2.1. High cost of oncology treatment
  3.1.3. Market Opportunities
    3.1.3.1. Growing strategic developments such as therapy launches, acquisitions, and mergers
    3.1.3.2. Surge in research and development of chemotherapy medicines

CHAPTER 4. GLOBAL METASTATIC CANCER TREATMENT MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT

  5.1.1. Assessment of the overall impact of COVID-19 on the industry
  5.1.2. Pre COVID-19 and post COVID-19 market scenario

CHAPTER 6. GLOBAL METASTATIC CANCER TREATMENT MARKET, BY TYPES OF CANCER

6.1. Market Snapshot
6.2. Global Metastatic cancer treatment Market by Types of Cancer, Performance - Potential Analysis
6.3. Global Metastatic cancer treatment Market Estimates & Forecasts by Types of Cancer, 2018-2028 (USD Million)
6.4. Metastatic cancer treatment Market, Sub Segment Analysis
  6.4.1. Breast Cancer
  6.4.2. Lung Cancer
  6.4.3. Prostate Cancer
  6.4.4. Melanoma
  6.4.5. Colorectal Cancer
  6.4.6. Others (Liver Cancer, Esophageal Cancer, among others)

CHAPTER 7. GLOBAL METASTATIC CANCER TREATMENT MARKET, BY TREATMENT TYPE

7.1. Market Snapshot
7.2. Global Metastatic cancer treatment Market by Treatment Type, Performance - Potential Analysis
7.3. Global Metastatic cancer treatment Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Million)
7.4. Metastatic cancer treatment Market, Sub Segment Analysis
  7.4.1. Chemotherapy
  7.4.2. Immunotherapy
  7.4.3. Hormone Therapy
  7.4.4. Others (Radiation Therapy, Surgery, among others)

CHAPTER 8. GLOBAL METASTATIC CANCER TREATMENT MARKET, BY END USER

8.1. Market Snapshot
8.2. Global Metastatic cancer treatment Market by End User, Performance - Potential Analysis
8.3. Global Metastatic cancer treatment Market Estimates & Forecasts by End User, 2018-2028 (USD Million)
8.4. Metastatic cancer treatment Market, Sub Segment Analysis
  8.4.1. Hospitals
  8.4.2. Clinics
  8.4.3. Other End Users

CHAPTER 9. GLOBAL METASTATIC CANCER TREATMENT MARKET, REGIONAL ANALYSIS

9.1. Metastatic cancer treatment Market, Regional Market Snapshot
9.2. North America Metastatic cancer treatment Market
  9.2.1. U.S. Metastatic cancer treatment Market
    9.2.1.1. Types of Cancer breakdown estimates & forecasts, 2018-2028
    9.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2028
    9.2.1.3. End User breakdown estimates & forecasts, 2018-202
  9.2.2. Canada Metastatic cancer treatment Market
9.3. Europe Metastatic cancer treatment Market Snapshot
  9.3.1. U.K. Metastatic cancer treatment Market
  9.3.2. Germany Metastatic cancer treatment Market
  9.3.3. France Metastatic cancer treatment Market
  9.3.4. Spain Metastatic cancer treatment Market
  9.3.5. Italy Metastatic cancer treatment Market
  9.3.6. Rest of Europe Metastatic cancer treatment Market
9.4. Asia-Pacific Metastatic cancer treatment Market Snapshot
  9.4.1. China Metastatic cancer treatment Market
  9.4.2. India Metastatic cancer treatment Market
  9.4.3. Japan Metastatic cancer treatment Market
  9.4.4. Australia Metastatic cancer treatment Market
  9.4.5. South Korea Metastatic cancer treatment Market
  9.4.6. Rest of Asia Pacific Metastatic cancer treatment Market
9.5. Latin America Metastatic cancer treatment Market Snapshot
  9.5.1. Brazil Metastatic cancer treatment Market
  9.5.2. Mexico Metastatic cancer treatment Market
9.6. Rest of The World Metastatic cancer treatment Market

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Top Market Strategies
10.2. Company Profiles
  10.2.1. Johnson and Johnson Services Inc.
    10.2.1.1. Key Information
    10.2.1.2. Overview
    10.2.1.3. Financial (Subject to Data Availability)
    10.2.1.4. Types of Cancer Summary
    10.2.1.5. Recent Developments
  10.2.2. Bristol Myers Squibb Company
  10.2.3. Eli Lilly and Company
  10.2.4. AstraZeneca
  10.2.5. GlaxoSmithKline Plc
  10.2.6. F. Hoffmann-La Roche Ltd.
  10.2.7. Novartis AG
  10.2.8. Merck and Co, Inc.
  10.2.9. Amgen Inc.
  10.2.10. Abbvie Inc.

CHAPTER 11. RESEARCH PROCESS

11.1. Research Process
  11.1.1. Data Mining
  11.1.2. Analysis
  11.1.3. Market Estimation
  11.1.4. Validation
  11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Metastatic cancer treatment Market, report scope
TABLE 2. Global Metastatic cancer treatment Market estimates & forecasts by region 2018-2028 (USD Million)
TABLE 3. Global Metastatic cancer treatment Market estimates & forecasts by Types of Cancer 2018-2028 (USD Million)
TABLE 4. Global Metastatic cancer treatment Market estimates & forecasts by Treatment Type 2018-2028 (USD Million)
TABLE 5. Global Metastatic cancer treatment Market estimates & forecasts by End User 2018-2028 (USD Million)
TABLE 6.
TABLE 7. Global Metastatic cancer treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Metastatic cancer treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Metastatic cancer treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Metastatic cancer treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Metastatic cancer treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Metastatic cancer treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Metastatic cancer treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Metastatic cancer treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Metastatic cancer treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. Global Metastatic cancer treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 18. U.S. Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. U.S. Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 20. Canada Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 21. Canada Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. Canada Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 23. UK Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 24. UK Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. UK Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 26. Germany Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 27. Germany Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. Germany Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 29. RoE Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 30. RoE Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. RoE Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 32. China Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 33. China Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. China Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 35. India Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 36. India Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. India Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 38. Japan Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 39. Japan Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. Japan Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 41. RoAPAC Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 42. RoAPAC Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. RoAPAC Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 44. Brazil Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 45. Brazil Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Brazil Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 47. Mexico Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 48. Mexico Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. Mexico Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 50. RoLA Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 51. RoLA Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. RoLA Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 53. Row Metastatic cancer treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 54. Row Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. Row Metastatic cancer treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 56. List of secondary sources, used in the study of global Metastatic cancer treatment Market
TABLE 57. List of primary sources, used in the study of global Metastatic cancer treatment Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered

LIST OF FIGURES

FIG 1. Global Metastatic cancer treatment Market, research methodology
FIG 2. Global Metastatic cancer treatment Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Metastatic cancer treatment Market, key trends 2021
FIG 5. Global Metastatic cancer treatment Market, growth prospects 2022-2028
FIG 6. Global Metastatic cancer treatment Market, porters 5 force model
FIG 7. Global Metastatic cancer treatment Market, pest analysis
FIG 8. Global Metastatic cancer treatment Market, value chain analysis
FIG 9. Global Metastatic cancer treatment Market by segment, 2018 & 2028 (USD Million)
FIG 10. Global Metastatic cancer treatment Market by segment, 2018 & 2028 (USD Million)
FIG 11. Global Metastatic cancer treatment Market by segment, 2018 & 2028 (USD Million)
FIG 12. Global Metastatic cancer treatment Market by segment, 2018 & 2028 (USD Million)
FIG 13. Global Metastatic cancer treatment Market by segment, 2018 & 2028 (USD Million)
FIG 14. Global Metastatic cancer treatment Market, regional snapshot 2018 & 2028
FIG 15. North America Metastatic cancer treatment Market 2018 & 2028 (USD Million)
FIG 16. Europe Metastatic cancer treatment Market 2018 & 2028 (USD Million)
FIG 17. Asia Pacific Metastatic cancer treatment Market 2018 & 2028 (USD Million)
FIG 18. Latin America Metastatic cancer treatment Market 2018 & 2028 (USD Million)
FIG 19. Global Metastatic cancer treatment Market, company market share analysis (2021)

















More Publications